Justin D. Gover
CIK 1754129 · Chief Executive Officer · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$137.8K
Companies
4
Total Filings
31
Lifetime Open-Market Net
-$8.20M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DSGN | Director | — | $10.97 | — | $0 | 3 | 2026-06-11 |
| XENE | Director | 2,645 | $52.10 | $137.8K | $0 | 4 | 2026-06-03 |
| CMPS | Director | — | $12.08 | — | $0 | 2 | 2026-05-29 |
| GW PHARMACEUTICALS PLC (GWPH) Delisted | Chief Executive Officer | 2,131,481 | $218.96 | $466.71M | -$8.20M | 21 | 2021-03-22 |
Recent Filings · Page 4 of 4
31 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-12-26 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Exer (M) | +45,240 | $59 | EDGAR |
Showing 31–31 of 31
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.